{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:50Z","timestamp":1786118930737,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/shk.0b013e3181818990","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T03:27:12Z","timestamp":1221017232000},"page":"23-29","source":"Crossref","is-referenced-by-count":20,"title":["IMPACT OF ANTIMICROBIAL RESISTANCE ON THE TREATMENT AND OUTCOME OF PATIENTS WITH SEPSIS"],"prefix":"10.1097","volume":"30","author":[{"given":"Silvia","family":"Figueiredo Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"8","key":"R1-6-20210213","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1086\/500318","article-title":"OUTCOMEREA Study Group: excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal.","volume":"42","author":"Garrouste-Orgeas","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"R2-6-20210213","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/000313480707300709","article-title":"Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging fatal problem.","volume":"73","author":"Castaldo","year":"2007","journal-title":"Am Surg"},{"issue":"5","key":"R3-6-20210213","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajem.2006.08.015","article-title":"Sepsis in the 21st century: recent definitions and therapeutic advances.","volume":"25","author":"Nguyen","year":"2007","journal-title":"Am J Emerg Med"},{"issue":"3","key":"R4-6-20210213","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":": Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"issue":"1","key":"R5-6-20210213","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diagmicrobio.2004.05.003","article-title":"Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).","volume":"50","author":"Biedenbach","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"R6-6-20210213","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/502271","article-title":"Outcomes associated with vancomycin-resistant enterococci: a meta-analysis.","volume":"24","author":"Salgado","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"R7-6-20210213","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"R8-6-20210213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bloodstream infection: a meta-analysis.","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"R9-6-20210213","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/499815","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections.","volume":"42","author":"Seybold","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"R10-6-20210213","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dkh366","article-title":"Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"54","author":"Kim","year":"2004","journal-title":"J Antimic rob Chemother"},{"issue":"6","key":"R11-6-20210213","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/377540","article-title":"Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.","volume":"37","author":"Kim","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"8","key":"R12-6-20210213","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/00365540210147516","article-title":"Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes.","volume":"34","author":"Ho","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"R13-6-20210213","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-002-1521-1","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.","volume":"28","author":"Du","year":"2002","journal-title":"Intensive Care Med"},{"issue":"10","key":"R14-6-20210213","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/502310","article-title":"Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.","volume":"25","author":"Kang","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"R15-6-20210213","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-6-24","article-title":"Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.","volume":"6","author":"Marra","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"2","key":"R16-6-20210213","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/AAC.50.2.498-504.2006","article-title":"Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.","volume":"50","author":"Tumbarello","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"R17-6-20210213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2006.05.010","article-title":"Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.","volume":"64","author":"Skippen","year":"2006","journal-title":"J Hosp Infect"},{"issue":"1","key":"R18-6-20210213","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.50.1.388-390.2006","article-title":"Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes.","volume":"50","author":"Marra","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"R19-6-20210213","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"10","key":"R20-6-20210213","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s00134-003-1957-y","article-title":"Improved survival of critically ill cancer patients with septic shock.","volume":"29","author":"Larche","year":"2003","journal-title":"Intensive Care Med"},{"issue":"6","key":"R21-6-20210213","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":": Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"4","key":"R22-6-20210213","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinids\/5.4.629","article-title":"Analysis of 1186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.","volume":"5","author":"Bryan","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"6","key":"R23-6-20210213","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":": Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"R24-6-20210213","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.","volume":"43","author":"Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"R25-6-20210213","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1469-0691.2007.01685.x","article-title":"Clinical variables associated with the isolation of Klebsiella pneumoniae expressing different extended-spectrum beta-lactamases.","volume":"13","author":"Garcia San Miguel","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"R26-6-20210213","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1469-0691.2005.01290.x","article-title":"High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.","volume":"12","author":"Goethaert","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"R27-6-20210213","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkl239","article-title":"The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.","volume":"58","author":"Zavascki","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"R28-6-20210213","first-page":"332","article-title":"Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.","volume":"30","author":"Rossolini","year":"2007","journal-title":"New Microbiol"},{"issue":"3","key":"R29-6-20210213","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2007.05.006","article-title":"Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa.","volume":"58","author":"Tam","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"R30-6-20210213","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/507290","article-title":"Polymyxins: a word of caution for prudent use of valuable \"old antibiotics\".","volume":"27","author":"Falagas","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"R31-6-20210213","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.shk.0000246899.73315.cb","article-title":"When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach.","volume":"27","author":"Falagas","year":"2007","journal-title":"Shock"},{"issue":"3","key":"R32-6-20210213","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JCM.01706-06","article-title":"Staphylococcal cassette chromosome mec and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones.","volume":"45","author":"Moroney","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"6","key":"R33-6-20210213","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/JCM.02311-06","article-title":"Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.","volume":"45","author":"Davis","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"12","key":"R34-6-20210213","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/509506","article-title":": Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?","volume":"194","author":"Voyich","year":"2006","journal-title":"J Infect Dis"},{"issue":"3","key":"R35-6-20210213","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1469-0691.2006.01635.x","article-title":"Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin.","volume":"13","author":"Monecke","year":"2007","journal-title":"Clin Microbiol Infect"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SHK.0b013e3181818990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:08:25Z","timestamp":1786036105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-200810001-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181818990","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}